HOMOLOGY MEDICINES
Homology Medicines, Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality acr... oss a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases and a robust intellectual property portfolio with issued composition of matter patents in the United States for its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
HOMOLOGY MEDICINES
Industry:
Alternative Medicine Biotechnology Genetics Health Care
Founded:
2015-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.homologymedicines.com
Total Employee:
101+
Status:
Active
Total Funding:
187 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Global Site Tag IPv6 Cloudflare JS CDN JS
Similar Organizations
Resolve Digital Health
Leading provider of standardized medical cannabis for patients suffering from cancer.
Reborna Biosciences
Reborna Biosciences is a research and development start-up focusing on the field of rare genetic diseases.
Revolution Global
Revolution Global is a producer of medical cannabis products to medical companies.
Numinus
Numinus utilizes psychedelic-assisted psychotherapy methods to bring holistic healthcare to patients.
Neurogene
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Nature’s Medicines
Nature’s Medicines is a multi-state vertically integrated cultivator and retailer of both medical and adult-recreational-use cannabis.
Northern Swan
Northern Swan is an investment firm focused on early and late-stage investments.
Nucleus
Nucleus combines genetic and non-genetic information and calculates the absolute risk scores for people for disease.
NuCicer
NuCicer is a crop genetics company pioneering ultra-high protein varieties of chickpea.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
VectivBio
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Matrixome
Matricome develops regenerative medicines by disseminating laminin E8 fragment technology.
Motif BioSciences
Motif BioSciences, a population genetics company, focuses on the genetic causes of major diseases using human genetic data from individuals.
Marizyme
Marizyme is a development-stage company dedicated to the commercialization of therapies that address the urgent need of higher mortality.
Molecular Assemblies
Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.
Microba Life Sciences
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.
Medoucine
Medoucine brings together practitioners of alternative medicine validated for you and who can consult with confidence!
MediBeacon
MediBeacon is an optical diagnostic company providing clinicians with critical information that improve patient care.
LOLIWARE
LOLIWARE is an award-winning materials tech company dedicated to replacing single-use plastics with seaweed.
Linc'well
Linc'well is a health care company providing SaaS for medical institutions in order to improve medical inefficiencies with technology.
LifeLabs
LifeLabs is a Canadian-owned company that has been serving the healthcare needs of Canadians for more than 50 years.
Scientist.com
Scientist.com is a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services.
Ariel Precision Medicine
Ariel Precision Medicine medicine solutions for diagnosis, monitoring, and treatment of diseases and disorders.
Azitra
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Amador Bioscience
Amador Bioscience provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
Attune Neurosciences
Attune Neurosciences is a medical device company.
Aleafia Health
Aleafia Health is a vertically integrated cannabis company that produces standardized, pesticide-free cannabis for patients in need.
Amplified Sciences
Amplified Sciences is a life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases.
Allelica
Allelica is a genomics software company driving the transition of Polygenic Risk Score from Genomic research to clinical application.
AusCann Group Holdings
With a scientific approach, AusCann is poised to assist the many Australians suffering from a range of conditions.
Beleave
Beleave Inc. is a biotech company and Beleave's wholly-owned subsidiary Beleave Kannabis Corp
Body and Mind
Body and Mind is a producer of cannabis that is lab-tested to ensure it is potent and free of contaminants.
Biofidelity
Biofidelity developed a revolutionary molecular diagnostics.
Reunion Neuroscience
Field Trip Health, Inc. providing simple, evidence-based therapies for healing and heightening engagement with the world.
Fluent BioSciences
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
The Green Solution
The Green Solution is a widely recognized and rapidly growing network of dispensaries with plans to expand across Colorado and beyond.
Jaguar Gene Therapy
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Krystal Biotech
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Willow Biosciences
Willow Biosciences is a multidisciplinary team of discovery biologists, biochemists and geneticists.
Scipher Medicine
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.
Science 37
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Siluria Technologies
Siluria Technologies is a material innovation company developing processes for transforming natural gas into chemicals and fuels.
Helix
Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.
Humm.ly
Humm.ly is making mindfulness fun and motivating through music therapy informed content!
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Harvest Health and Recreation
Harvest Health and Recreation is a cannabis company and multi-state operator that provides products to consumers and dispensaries.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Humane Genomics
Humane Genomics is a virus development platform that develops artificial viruses to cure diseases.
Hound Labs
Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement.
Humabiologics
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers.
Ilera Healthcare
Ilera Healthcare is a premier medical marijuana cultivator, processor, and dispenser.
I Peace
I Peace, Inc. is a CDMO specializing in iPSC-derived cell products. We provide cGMP manufacturing service and personal iPSC banking service.
Indee Labs
Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery.
Gendius
Gendius is a diabetes management platform helping its consumers check and level diabetes.
Genbioma
Genbioma is a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions.
GenSight Biologics
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
OpGen
OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease.
Orbit Discovery
Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases.
Cystetic Medicines
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.
Color
Color is a complete platform for healthcare delivery.
Compassionate Cultivation
Compassionate Cultivation is a medical cannabis company that grows, processes, and dispenses CBD medicine.
Cybin
Cybin is a life sciences company dedicated in advancing psychedelic therapeutics with the goal of transforming mental healthcare.
Clear Genetics
Clear Genetics is a digital health company dedicated to the thoughtful integration of genetics into routine patient care.
Colossal Biosciences
Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics.
AEENA Dx
AEENA Dx is developing a saliva-based platform for the detection of cancer and other diseases
Pure Body Zen
Pure Body Zen is a provider of CBD products for veterans, and those who suffer from PTSD and drug addiction.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2020-08-01
Board_observer
Board_member
Board_member
Board_member
2016-01-01
Current Employees Featured
Brad Smith Chief Financial Officer @ Homology Medicines
Chief Financial Officer
2017-04-01
Laura Smith Scientific Co-founder & Project Lead Scientist @ Homology Medicines
Scientific Co-founder & Project Lead Scientist
2016-07-01
Theresa McNeely Chief Communications Officer & Patient Advocate @ Homology Medicines
Chief Communications Officer & Patient Advocate
2018-01-01
Albert Seymour Chief Scientific Officer @ Homology Medicines
Chief Scientific Officer
2016-04-01
John Thompson VP of Genomics and Computational Biology @ Homology Medicines
VP of Genomics and Computational Biology
Gabriel M. Cohn Chief Medical Officer @ Homology Medicines
Chief Medical Officer
2019-12-01
Arthur Tzianabos President & Chief Executive Officer @ Homology Medicines
President & Chief Executive Officer
2016-05-01
Saswati Chatterjee Co-Founder @ Homology Medicines
Co-Founder
2015-01-01
Tim Kelly Chief Technical Operations Officer @ Homology Medicines
Chief Technical Operations Officer
2018-03-01
Founder
Stock Details
Investors List
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - Homology Medicines
Rock Springs Capital
Rock Springs Capital investment in Series B - Homology Medicines
Temasek Holdings
Temasek Holdings investment in Series B - Homology Medicines
Deerfield
Deerfield investment in Series B - Homology Medicines
5AM Ventures
5AM Ventures investment in Series B - Homology Medicines
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Homology Medicines
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Homology Medicines
Vida Ventures
Vida Ventures investment in Series B - Homology Medicines
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Homology Medicines
Novartis
Novartis investment in Series B - Homology Medicines
Official Site Inspections
http://www.homologymedicines.com Semrush global rank: 2.74 M Semrush visits lastest month: 5.93 K
Unable to get host informations!!!
More informations about "Homology Medicines"
Q32 Bio Announces Closing of Merger with Homology Medicines …
Mar 25, 2024 -- Q32 Bio to focus on advancement of bempikibart (ADX-914) in ongoing atopic dermatitis (AD) and alopecia areata (AA) Phase 2 clinical trials and commencement of ADX …See details»
Q32 Bio and Homology Medicines Announce Merger Agreement
Nov 16, 2023 –The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio’s two clinical development candidates, bempikibart (ADX-914) in Phase 2 for the …See details»
Homology Medicines - Crunchbase Company Profile & Funding
Homology Medicines, Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing …See details»
Homology Medicines - Overview, News & Similar companies
May 9, 2024 Homology Medicines contact info: Phone number: (781) 301-7277 Website: www.homologymedicines.com What does Homology Medicines do? Homology Medicines, Inc. …See details»
Homology Medicines Company Profile - Office Locations ... - Craft
May 24, 2022 See insights on Homology Medicines including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Homology Medicines Announces $60 Million Equity Investment
Tmcneely@homologymedicines.com 781- 301-7277 Media Contact: Cara Mayfield Senior Director, Patient Advocacy and Corporate Communications …See details»
Homology Medicines Company Profile 2024: Valuation, Investors ...
Homology Medicines General Information Description. Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients …See details»
Homology Medicines Announces $60 Million Equity Investment
BEDFORD, Mass., November 9, 2020 – Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc. (NYSE: PFE) has agreed to make a $60 …See details»
Homology Medicines Announces Closing of Deal Leveraging its …
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the successful closing of the deal with …See details»
Homology Medicines Appoints Albert Seymour, Ph.D., Chief
Sep 6, 2022 For more information, visit www.homologymedicines.com. Forward-Looking Statements ... CEO & President and Chief Scientific Officer, respectively, and they helped to …See details»
Q32 Bio and Homology Medicines Announce Merger Agreement
Nov 16, 2023 Management and Organization Upon closing of the proposed transaction, the combined company will be led by current members of the Q32 Bio leadership team including: …See details»
Homology Medicines Announces Promotion of Tim Kelly to Chief …
Apr 12, 2021 Company ContactsTheresa McNeelyChief Communications Officer and Patient Advocatetmcneely@homologymedicines.com781-301-7277 Media Contact:Marisa …See details»
Homology Medicines Provides Update on pheEDIT and juMPStart …
Jan 4, 2023 Homology shared new preclinical data today supporting the immunosuppression regimen incorporated in both the pheEDIT and juMPStart trials. In non-human primates …See details»
Homology Medicines Emerges with Next Generation Gene Editing …
LEXINGTON, Mass., May 2, 2016 /PRNewswire/ -- Homology Medicines, Inc., a newly formed genetic medicines company translating proprietary, next generation gene editing and gene …See details»
Homology Medicines Announces New Approach to Leverage …
Apr 28, 2021 Company Contacts Theresa McNeely Chief Communications Officer and Patient Advocate tmcneely@homologymedicines.com781-301-7277 Media Contact: Marisa Citrano …See details»
Homology Medicines Announces Presentations on its Expanding …
May 13, 2021 Company ContactsTheresa McNeelyChief Communications Officer and Patient Advocatetmcneely@homologymedicines.com781-301-7277 Media Contact:Marisa …See details»
Homology Medicines Announces World’s First Gene Editing
Oct 12, 2021 tmcneely@homologymedicines.com 781-301-7277. Media Contact: Cara Mayfield Vice President, Patient Advocacy and Corporate Communications …See details»
Homology Medicines Reports Fourth Quarter and Full Year 2022 …
Mar 9, 2023 Fourth Quarter 2022 and Full Year Financial Results. Net loss for the quarter ended December 31, 2022 was $(34.3) million or $(0.60) per share, compared to a net loss of $(33.6) …See details»
Homology Medicines Announces First Data from IND-Enabling
May 16, 2023 cmayfield@homologymedicines.com 781-691-3510 Investor Contact: Bill Slattery, Jr. Vice President, Investor Relations bslattery@homologymedicines.comSee details»
Homology Medicines Announces Optimized, In Vivo Gene Therapy …
Aug 11, 2022 In the murine model of MLD, a single I.V. administration of the optimized gene therapy candidate, which uses one of Homology’s proprietary AAVHSC capsids, resulted in:See details»